|
| |
 |
| ABSTRACTS OF ISRT-2018 (WARMTH) IN HELSINKI |
|
| Year : 2019 | Volume
: 18
| Issue : 2 | Page : 204 |
|
Preface
| Date of Web Publication | 5-Apr-2019 |
Correspondence Address:
  | Check |
How to cite this article:
. Preface. World J Nucl Med 2019;18:204 |
The World Association of Radiopharmaceutical Therapy (WARMTH) held a 3-day event, International Symposium on Radiopharmaceutical Therapy (ISRT), 18-20 November 2018 in Helsinki, Finland. The objectives of the conference were to evaluate the current status of radiopharmaceutical therapy in the world in general, to exchange information on the current advances in the field between scientists from developed and developing countries; to interact with user groups (clinicians, oncologists, surgeons, radiopharmacists, medical physicists, etc.) and to bring them the most important information in the field, and to define future directions. The major emphasis of the conference involved the end-users and stake holders of radionuclide therapy, e.g., oncologists, endocrinologists, radiation oncologists, haematologists, physicians and surgeons. The Conference covered topics and discussed issues on all aspects of radiopharmaceutical therapy including a number of plenary lectures, papers, posters and panel discussions.
The titles of the sessions as follows:
- NUCLEAR CARDIOLOGY
- NEW TRENDS IN ONCOLOGY AND PRECISION MEDICINE
- Ajit Padhy Oration
- RADIOEMBOLISATION AND LIVER THERAPIES
- NEW RADIONUCLIDE THERAPIES / RADIATION HAZARDS/ SAFETY ISSUES
- PROSTATE CANCER: PSMA RADIOLIGAND THERAPY (PRLT) – WHAT DO WE KNOW AND WHAT IS NEW?
- THYROID CANCER – QUO VADIS?
- PEPTIDE RECEPTOR/ NEW THERAPIES
- NEW ALPHA- THERAPIES
- FUTURE ASPECTS OF COLLABORATION OF WARMTH, IAEA AND WFNMB
There were more than 60 presentations in International Symposium on Radiopharmaceutical Therapy
Helsinki, 18-20 November 2018. Most of the abstracts are presented in this booklet.
Kalevi Kairemo, President, ISRT-2018
Irene J Virgolini, President, WARMTH
|
Users Online: 119 
